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Saccharomyces cerevisiae DNA polymerase epsilon
(pol e) is essential for chromosomal replication. A major
form of pol e purified from yeast consists of at least four
subunits: Pol2p, Dpb2p, Dpb3p, and Dpb4p. We have
investigated the protein/protein interactions between
these polypeptides by using expression of individual
subunits in baculovirus-infected Sf9 insect cells and by
using the yeast two-hybrid assay. The essential sub-
units, Pol2p and Dpb2p, interact directly in the absence
of the other two subunits, and the C-terminal half of
POL2, the only essential portion of Pol2p, is sufficient
for interaction with Dpb2p. Dpb3p and Dpb4p, non-es-
sential subunits, also interact directly with each other
in the absence of the other two subunits. We propose
that Pol2pzDpb2p and Dpb3pzDpb4p complexes interact
with each other and document several interactions be-
tween individual members of the two respective com-
plexes. We present biochemical evidence to support the
proposal that pol e may be dimeric in vivo. Gel filtration
of the Pol2pzDpb2p complexes reveals a novel heterotet-
rameric form, consisting of two heterodimers of
Pol2pzDpb2p. Dpb2p, but not Pol2p, exists as a ho-
modimer, and thus the Pol2p dimerization may be me-
diated by Dpb2p. The pol2-E and pol2-F mutations that
cause replication defects in vivo weaken the interaction
between Pol2p and Dpb2p and also reduce dimerization
of Pol2p. This suggests, but does not prove, that dimer-
ization may also occur in vivo and be essential for DNA
replication.
DNA polymerases (pol) 1 play essential roles in the duplica-
tion of genetic material and DNA repair in both prokaryotes
and eukaryotes (1). In Saccharomyces cerevisiae there exist
three essential nuclear DNA polymerases, pol a, d, and e (2–4).
Despite years of study, several perhaps equally plausible mod-
els exist for the function of each polymerase during DNA rep-
lication. Pol a plays the role of a primase in the initiation of
DNA replication on both leading and lagging strands in the
simian virus 40 in vitro system (5). Pol d and pol e are required
for the bulk of the replication on the leading and lagging
strands (6–8). The precise location of pol d and pol e on leading
and lagging strands, however, is not known. Pol a, pol d, and
pol e have also been shown to participate in DNA repair (1).
Polymerase e was the first proofreading polymerase purified
from yeast (2). Since then it has been purified from a number of
sources including Schizosaccharomyces pombe, the silkworm
Bombyx mori, and HeLa cells (3–7). The S. cerevisiae pol e
consists of four subunits, Pol2p, Dpb2p, Dpb3p, and Dpb4p,
with an estimated stoichiometry of 1:1:4:4 (4). These four pro-
teins are encoded by the POL2, DPB2, DPB3, and DPB4 genes
(4, 8).2 The POL2 gene encodes the 256-kDa catalytic subunit of
pol e (8). Mammalian and S. pombe Pol2p show strong sequence
similarity to yeast Pol2p (7, 9). The DPB2, DPB3, and DPB4
genes encode the remaining 80-, 34-, and 29-kDa subunits of
the yeast pol e holoenzyme, respectively (4, 10, 11).2 A func-
tional and structural human homolog of DPB2, DPE2, has
recently been described (12). Dpb2p has also recently been
shown to share amino acid similarity with the B subunits of pol
a (Pol12p), pol d (Pol31p), and many other DNA polymerases
(13). DPB3 and DPB4 from other sources have recently been
identified (27). The POL2 and DPB2 genes are essential for the
growth of yeast (8, 10), and the phenotype of temperature-
sensitive pol2 and dpb2–1 mutants suggests a role for each in
DNA replication (10). However, the precise function of DPB2 is
not known. The DPB3 gene is non-essential, but dpb3 mutants
have increased frequency of spontaneous mutation as expected
of a DNA replication defect (11). The role of the DPB4 gene is
currently unknown. Genetic analysis indicates that DPB11,
which is essential for the initiation of DNA replication, may
also be important for the function of the pol e complex (14);
however, Dpb11p does not seem to copurify with the holoen-
zyme. Another protein, encoded by SLD2 (also known as
DRC1), also appears to participate in DNA replication through
interaction with Dpb11p and pol e, but does not copurify with
the complex (15, 16).
Early studies revealed two main classes of replication-defec-
tive pol2 mutants. One class mapped to the N-terminal cata-
lytic region, pol2–9 and pol2–18. The second class mapped in
the very C-terminal amino acids, pol2–11 and pol2–12 (17–19).
This suggested that the protein might have at least two essen-
tial functions. Supporting this idea, the C-terminal mutants
were defective both in DNA replication and in the surveillance
mechanisms that monitor DNA damage and replication blocks
during S phase, the S/M, and the intra-S checkpoints (19, 20).
The catalytic domain mutants, pol2–9 and pol2–18, in contrast,
were defective only in DNA replication (19). We made serial 10
amino acid deletions over the C-terminal 120 amino acids to
identify the amino acids specifically involved in the checkpoint
function of the C terminus. A 20-amino acid stretch between
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two putative zinc fingers (see Fig. 8) was critical for both DNA
replication and the S/M checkpoint. Given the phenotypes of
the C-terminal mutants, we reasoned that the mutations might
affect either protein/DNA or protein/protein interactions. In
fact, the mutations affected at least two important protein/
protein interactions. We discovered that the Pol2 protein
dimerized using two-hybrid assays, and that the inter-zinc
finger mutants failed to do so, suggesting that the dimerization
was not an artifact of the two-hybrid assay (21). Second, we
found that the C terminus of Pol2p interacted strongly with the
Dpb2p subunit by two-hybrid analysis, and that the inter-zinc
finger mutations also destabilized this interaction, although
they did not abolish it (21). These results led to the model that
Pol2p C-terminal amino acids were involved in assembling an
active holoenzyme, as also suggested by Sugino, Araki, and
collaborators (22) based on studies of the holoenzyme purified
from yeast.
The importance of the Pol2p C terminus at the replication
fork was made clear when it was found that the entire catalytic
domain of Pol2p can be deleted and cells remain viable, as long
as the C-terminal 110-kDa fragment of the protein is intact (23,
24). Thus, it is the C-terminal half of the protein that provides
the only non-redundant essential role in DNA replication,
rather than, as would have been expected, the catalytic polym-
erase activity.
The large size of the pol e complex currently precludes direct
structural studies. However, a first order picture of the ar-
rangement of subunits that assemble into pol e can be obtained
by methods similar to those used to analyze the Escherichia
coli replicase, i.e. purification of individual subunits or mix-
tures of subunits and analysis of their interactions. We have
analyzed the protein/protein interactions in pol e by both bio-
chemical analysis and two-hybrid assay of pairwise combina-
tions of subunits. We find that Pol2p and Dpb2p form a stable
complex and that Dpb3p and Dpb4p form a tight complex. It
seems logical to propose that these two subcomplexes may
interact to form the holoenzyme observed in yeast extracts,
since Pol2p and Dpb3p interact strongly. We also find that the
Pol2pzDpb2p complex is dimeric, with dimerization of the cat-
alytic subunit, Pol2p, being mediated by dimerization of
Dpb2p. Mutations that reduce Pol2p/Dpb2 interaction and
dimerization have severe growth defects. This suggests, but
does not prove, that pol e is active as a dimeric protein.
EXPERIMENTAL PROCEDURES
Materials—Plasmid PTZ18 was from Bio-Rad. Plitmus39, M13KO7,
restriction enzymes, T4 DNA ligase, and Klenow large fragment were
from New England Biolabs. E. coli CJ236 and mutagenesis kit were
obtained from Bio-Rad. Grace’s medium and supplements for culturing
Sf9 insect cells were from Invitrogen. PfastbacI and pfastbacHTb bacu-
lovirus vectors, E. coli DH10bac, Cellfectin reagent, SFM medium for
insect cells, and heat-inactivated fetal bovine serum were obtained from
Life Technologies, Inc. Agarose Ni21/NTA beads were from Qiagen.
Oligonucleotides were synthesized by the oligonucleotide facility at
California Institute of Technology. Plasmid miniprep kits were from
Qiagen. Western blotting reagents and nitrocellulose membrane were
obtained from Amersham Pharmacia Biotech. The His6 monoclonal
antibody was from Sigma. Polyclonal antibody for the pol e complex was
provided by Dr. Akio Sugino (Osaka University, Osaka, Japan).
Construction of POL2, DPB2, DPB3, and DPB4 Recombinant Bacu-
loviruses—The pSEY18-POL2 vector (17) was digested with SacI, and
the purified POL2 fragment was cloned at the SacI site in the PTZ18
vector to create PTZ18-POL2. To excise the C terminus of POL2,
PTZ18-POL2 was digested with BsrGI and the vector was ligated with
itself. The ligated vector containing the N terminus of POL2 was trans-
formed into E. coli CJ236, and cells were infected with M13KO7 phage
to make a POL2 phagemid. Uracil containing single-stranded DNA
phagemid template was prepared as described earlier (21). The single-
stranded DNA template was annealed to an oligonucleotide, which was
designed to introduce a SacI restriction enzyme site near the ATG start
of POL2. Mutagenesis was carried out as described (21). The mutagenic
oligonucleotide used is as follows: P1, 59-C AAA CAT CAT A G A GC T
C TC CCC TGA G-39.
The mutation was confirmed by DNA sequencing. This resulted in
PTZ181-POL2. The C-terminal BsrGI fragment of POL2 (21) was sub-
cloned into the PTZ181-POL2 to reconstitute the full-length POL2 gene
resulting in PTZ182-POL2. For pol2-E and pol2-F mutants, plitmus39
containing the mutagenized C terminus (21) was used to reconstitute
the full-length pol2-E and pol2-F, which resulted in PTZ183-POL2 and
PTZ184-POL2, respectively. The PTZ182-POL2, PTZ183-POL2, and
PTZ184-POL2 were digested with SacI, and the purified fragment was
subcloned in the pfastbacI baculovirus vector at SacI site. Colonies were
screened by colony hybridization, and positive clones were confirmed by
restriction digestion and DNA sequencing.
The DPB2 gene was excised from the pGal4BD-DPB2 vector (21) by
NcoI/SalI digestion and cloned in the pfastbacHTb vector. The DPB3 gene
(21) was cloned at BamHI/XhoI sites in pfastbac1 and pfastbacHTb vec-
tors. The open reading frame of clone YDR121W, which encodes DPB4,2
was synthesized by PCR using yeast genomic DNA as template and
cloned at BamHI/XhoI in pfastbac1 and pfastbacHTb vectors. (The West-
ern blot in Fig. 3 confirms that the gene we cloned actually encodes
Dpb4p.) The DPB2, DPB3, and DPB4 genes in pfastbacHTb have a His6
epitope and 16 additional amino acids at the N terminus. The oligonu-
cleotides used for PCR cloning of DPB3 and DPB4 are as follows: DPB31,
59-C AAC CGT GTT GGA TCC AAA ATG TCC AAC TTA G-39; DPB32,
59-CA ATA ATC TCG AGA TCA CTA AGG ATC GGT G-39; DPB41,
59-GAC CAT ATA TTT GGA TCC ACG ATG CCA CC-39; and DPB42,
59-TAG ACA GTT TCC CTC GAG GGG TTA CGT TTG-39.
The C terminus of POL2 was prepared by PCR (25) and cloned at
SacI/XhoI sites in pfastHT1 and pfastHA baculovirus vectors. pfastHT1
and pfastHA were made by inserting oligonucleotide cassettes shown
below into pfastbac1. The pfastHT1 and pfastHA vectors contain His6
and HA epitopes at BamHI/EcoRI sites, respectively. The oligonucleo-
tides used are as follows: HT1, 59-GA TCC ATG TCG CAT CAT CAT
CAT CAT CAT GGT G-39; HT2, 59-AA TTC ACC ATG ATG ATG ATG
ATG ATG CGA CAT G-39; HA1, 59-GA TCC ATG TAC CCA TAC GAC
GTC CCA GAC TAC GCT G-39; HA2, 59-AA TTC AGC GTA GTC TGG
GAC GTC GTA TGG GTA CAT G-39; K1, 59-G CCC TCG GAG AGA GCT
CTC ATG GAC GAG G-39; K2, 59-CA TTG AAC CTC GAG TTA TAT
ACT G-39.
The preparation of baculoviruses was performed using the Bac to Bac
system from Life Technologies Inc. Briefly, recombinant pfastbacI or
pfastHTb vectors were transformed into E. coli DH10bac cells. Bacmid
DNA was prepared according to the manufacturer’s instructions and
immediately transfected into log phase Sf9 insect cells using Cellfectin
reagent. The culture supernatant containing the baculovirus particles
was collected after 3 days, amplified twice, and stored in darkness at
4 °C. As a control, pfastbacI vector plasmid was used to prepare wild
type baculovirus.
Expression and Purification of the pol e Subunits—For expression of
proteins, 70 3 106 log phase Sf9 insect cells were layered on four
175-cm2 tissue culture flasks. After cells were attached (1 h), superna-
tant was removed and cells were infected with viral supernatant at
multiplicity of infection of 10 for POL2 (or pol2-F mutant), 5 for DPB2,
5 for DPB3, and 5 for DPB4. The cells were incubated for 2 h at room
temperature with gentle rocking. Then, 5 ml of additional Grace’s
complete medium was added and cells were incubated at 27 °C. After 2
days, cells were harvested, washed once with cold 13 Tris-buffered
saline, flash frozen in liquid N2, and stored at 270 °C. For pairwise
coinfections, Sf9 cells were infected with the corresponding baculovi-
ruses as described above and incubated at 27 °C for 2 days. To purify
various pol e subunits, the frozen cells (70–100 3 106 cells) were thawed
once on ice and then resuspended in 2 ml of buffer A (20 mM Tris, 100
mM NaCl, 5 mM EGTA, 20% glycerol, pH 7.9) containing leupeptin (20
mg/ml) and pepstatin A (20 mg/ml). After lysis, cells were kept on ice for
15 min and centrifuged at 12,000 rpm in a microcentrifuge for 10 min
and supernatant was recovered. 300 ml of Ni21/NTA-agarose beads
(50:50 in buffer A) were added to the supernatant, and the mixture was
kept at 4 °C with end to end rotation for 2 h. All further purification
steps were carried out at 4 °C unless otherwise stated. After binding of
the proteins, beads were centrifuged at 1000 rpm using a swinging
bucket centrifuge and the unbound protein fraction was collected. The
beads were extensively washed (8 3 0.8 ml) with buffer A. To elute
proteins, beads were mixed with 350 ml of buffer B (20 mM Tris, 100 mM
NaCl, 20% glycerol, pH 7.9) containing 0.3 M imidazole with rotation for
30 min. The mixture was centrifuged, and the supernatant containing
the eluted proteins was collected. Samples were stored at 270 °C. The
total protein, unbound protein, and eluted protein fractions were ana-
lyzed using 10% SDS-PAGE and Western blotting. The protein concen-
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tration was determined using Bradford assay using bovine g-globulin as
a standard.
Gel Filtration Analysis—The SMART system (Amersham Pharmacia
Biotech) and precision column Superdex 200 PC (2.4 ml) (Amersham
Pharmacia Biotech) were used for the analysis. The column was equil-
ibrated at 4 °C with 50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.5 M KCl,
and 10% glycerol. 50 ml (50 mg) of the protein eluted from the Ni21/NTA
column was injected on the column. The flow rate was set at 40 ml/min,
and protein fractions (40 ml) were collected. The fractions were analyzed
by 10% SDS-PAGE and assayed for DNA polymerase activity using
poly(dA)/oligo(dT) as a DNA template as described below. Marker pro-
teins (Amersham Pharmacia Biotech) were chromatographed in a sim-
ilar manner. To cleave the N-terminal His6 sequence, the proteins
(20–30 mg) were incubated with rTEV protease enzyme as described in
the manufacturer’s instructions (Life Technologies, Inc.). The cleaved
peptide and the rTEV protease were removed by adding Ni21/NTA
beads to the protein mixture and collecting the unbound fraction.
Yeast Two-hybrid Protein/Protein Interactions—The lexA DNA bind-
ing domain (LEX A-BD) plasmid BTM116, provided by Stanley Fields
(University of Washington, Seattle, WA), and Gal4 activation domain
plasmid pACT2 (Matchmaker two-hybrid system; CLONTECH) were
used for cloning the C-terminal fragment of POL2 (aa 1265–2222),
DPB2, DPB3, DPB4, and the N-terminal fragment of POL2 (aa 1–1265).
Construction of the pACT2/C terminus POL2, DPB2, and DPB3 were
described previously (21). pACT2/N terminus POL2 and DPB4 were
cloned by generating a PCR product using yeast genomic DNA as a
template and primers to give flanking SmaI/XhoI sites (59-CTGCCCG-
GGCATGTTTGGCAAGAAAAAAAACAACGG-39 and 59-GGTCGCCTC-
GAGCTAGTCCATGGAAGGAATCTCCG-39) and NcoI/BamHI sites (59-
CATATTTTTTCCATGGCGATGCCACCA-39 and 59-TACTAGACAGG-
ATCCATAGCGGG-39).
Plasmid pBTM116BD-C terminus POL2 was cloned by generating a
PCR product using pK1 (21) with primers generating flanking SmaI/
BamHI sites (59-AGATTCCTTCCCCGGGCGAGGACTATGT-39 and
59-CGTTATATACTGGATCCTCATATGGTCAAATC-39).
pBTM116BD-N-terminus POL2, DPB2, DPB3, and DPB4 were cloned
via the univector plasmid-fusion system (UPS) (25). UPS uses Cre recom-
binase to facilitate a loxP site-specific recombination event. DPB2, DPB3,
and DPB4 were excised from previously isolated pAS2–1 vectors (21) and
ligated into the pUNI15 vector at the NcoI and BamHI sites, downstream
of the loxP site, 59-ATAACTTCGTATAGCATACATTATACGAAGTTAT-
39. The N terminus POL2 was cloned into pUNI15 downstream of the loxP
site after PCR with SmaI primers 59-CTGCCCGGGCATGATGTTTGGC-
AAGAAAAAAAACAACGG-39 59-GGTCGCGCCCGGGTAGTCCATGGA-
AGGAATCTCCG-39. A loxP site was inserted into the polylinker of
pBTM116 at SmaI/PstI, designated pBTM116loxP. The respective
pUNI15 plasmids were recombined with pBTM116loxP, and the
pBTM116BD-N-terminus POL2, DPB2, DPB3, and DPB4 plasmids were
isolated as described (25). P1 Cre recombinase was either from Novagen
or purified from GST-Cre-expressing pBL21DE3plys/pQL123 (25).
(pUNI15 and pQL123 plasmids were supplied by the Elledge laboratory,
Baylor College of Medicine, Houston, TX).
The L40 two-hybrid strain (MATa hisD200 trp1–901 leu2–3, 112 ade2
lys2–801am URA3::(lexAop)8 -lacZ LYS2::(lexAop)4-HIS3) (26) was co-
transformed with the binding domain and activation domain fusion
constructs using the polyethylene glycol/lithium method. Transfor-
mants were selected on Leu2/Trp2/His2 synthetic agar plates plus or
minus 1 mM 3-amino-1,2,4-triazole incubated at 30 °C for 3–5 days.
Colonies that grew were tested for b-galactosidase activity using a filter
lift assay and then quantified in a subsequent b-galactosidase assay
(both as per instructions from CLONTECH). b-Galactosidase units of
activity were calculated as b- galactosidase activity 5 1000 3 A420/(t 3
v 3 A600), where t 5 time (min) required for the reaction and v 5 0.1 3
concentration factor. All quantitative measurements were done in rep-
licates of 4–11n and are reported as an average 6 S.D.
Polymerase Assays—The polymerase assays were as described, using
poly(dA)/oligo(dT)10 (1:20, template to primer chains) as DNA template (4,
5). Reaction mixtures (60 ml) consisted of 50 mM Tris-HCl, pH 7.5, 2 mM
dithiothreitol, 10% glycerol, 8 mM MgCl2, 17 mg/ml poly(dA)/oligo(dT)10,
120 mM KCl, 100 mg/ml bovine serum albumin, and 50 mM [3H] dTTP (100
cpm/pmol). The poly(dA) /oligo(dT)10 mixture was annealed in 25 mM
Hepes, pH 7.1, 60 mM KCl prior to the reaction. The reactions were
conducted at 37 °C for 15 min. The reactions were stopped by spotting the
reaction mixture on Whatman DE81 filter paper (2.4 cm diameter). The
filters were washed (five times) with 0.5 M Na2HPO4, two times with
water, and then rinsed with 95% ethanol. Filters were dried, 3 ml of
scintillation mixture was added, and radioactivity was measured. One
unit of polymerase activity is defined as 1 nmol of dNMP incorporated/h.
Mutagenesis and Subcloning—The point mutations in the inter-zinc
finger domain of POL2 were constructed as before (20). The oligonu-
cleotides used for the mutagenesis are as follows: L2146D (59-G TTT
TTC AAT GTC GTG TTC TTG C-39), L2150D (59-GAT ATC AGA ACG
GTC TTT TTC AAT C-39), and L2146D,L2150D (59-GAT ATC AGA ACG
GTC TTT TTC AAT GTC GTG TTC TTG CAA C-39).
The mutations were verified by automated DNA sequencing, and the
full-length POL2 gene was reconstituted in pRS314 as described previ-
ously (21).
RESULTS
Interactions between the Essential Subunits, Pol2p and
Dpb2p—If two proteins directly contact each other, one of
which is tagged with a His6 peptide, it is expected that the
protein without the His6 tag will co-purify with the protein
fused to the His6 peptide upon Ni
21/NTA chromatography. We
have used this as the basis of a strategy to identify putative
protein contacts between known subunits of pol e. In order to
assess the interaction of Pol2p with Dpb2p subunit, Sf9 cells
were infected with Pol2pzHis6-Dpb2p recombinant baculovi-
ruses. After 48 h, cells were harvested, extracts prepared, and
proteins purified by Ni21/NTA affinity chromatography. As
shown in Fig. 1A, Pol2p coeluted from Ni21/NTA with His6-
Dpb2p (Fig. 1A, lane 1E). Pol2p could not be detected in frac-
tions from cells carrying only Pol2p virus without His6-Dpb2p
(Fig. 1A, lane 2E). Thus, Pol2p interacts directly with Dpb2p.
Previous two-hybrid analysis had suggested that the C-ter-
minal fragment of Pol2p (110 kDa, aa 1265–end) is sufficient
for interaction between Pol2p and Dpb2p (21). We confirmed
this biochemically by showing that when the truncated HA-
Pol2p (aa 1265–end) and His6-Dpb2p were coexpressed, HA-
Pol2p (aa 1265–end) coeluted with His6-Dpb2p from Ni
21/NTA
beads (Fig. 1, B (lane 1) and C (lane 3)).
Two C-terminal Mutations, pol2-E and pol2-F, Which Show
Growth Defects, Weaken Interaction between Pol2p and
Dpb2p—The Pol2-Fp has a deletion of aa 2153–2162, between
the two putative C-terminal zinc fingers (21). Previously, using
two-hybrid analysis, we demonstrated that pol2-Fp showed
reduced affinity for DPB2 (21). Here, we further investigated
the pol2-Fp/Dpb2p interactions in vivo and in vitro. Dosage
suppression has been used to argue for protein/protein inter-
action in the past. For example, overexpression of SLD2 (also
known as DRC1) suppresses dpb11 growth defects, and the two
proteins have been shown to interact by coimmunoprecipita-
tion from yeast extracts (15, 16). The ability of the DPB2 gene
expressed under the GAL1,10 promoter in a high copy number
plasmid to suppress the temperature-sensitive phenotype of
pol2-F was tested. As shown in Fig. 2A, pol2-F was able to grow
at 37 °C when DPB2 was induced by galactose but not when
Gal1,10 was repressed by glucose. This supports the idea that
the two proteins may interact and thus stabilize the thermo-
labile pol2-Fp.
To analyze the interactions of pol2-Fp and Dpb2p biochemi-
cally, Sf9 cells were coinfected with pol2-Fp and His6-Dpb2p
recombinant baculoviruses and the ability to form a complex
was assessed using Ni21/NTA beads as above. As predicted, the
pol e antibody showed only a very weak pol2-Fp band associ-
ated with the His6-Dpb2p (Fig. 2B, lane 1E).
Since assays for catalytic activity can be more sensitive than
Western blotting, the polymerase activity of the affinity-puri-
fied fractions was also used to compare the amount of Pol2p
and mutant pol2-F protein copurifying with His6-Dpb2p. As
shown in controls in Table I, no DNA polymerase activity
eluted from the Ni21/NTA column when cells were infected
with His6-Dpb2p. Nor was there any detectable DNA polymer-
ase activity in Ni21/NTA column fractions when cells were
infected with untagged Pol2p virus (Table I). DNA polymerase
activity was detected in Pol2pzHis6-Dpb2p and pol2-FpzHis6-
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Dpb2p coinfections, however. As shown in Table I, the activity
of pol2-FpzHis6-Dpb2p was 10-fold reduced compared with
wild-type Pol2pzHis6-Dpb2p. However, the pol2-F complex po-
lymerase activity was still significantly (50-fold) higher than
the control lacking any Pol2p (Table I). We conclude that there
is residual but reduced interaction between pol2-Fp and
Dpb2p. Taken together with the Western blot, we attribute the
reduction in activity to reduction in the amount of pol2-F pro-
tein present, although we cannot rule out that the polymerase
activity itself may also be reduced. Thus, the pol2-F mutation
reduces but does not abolish Pol2p/Dpb2p interaction. A simi-
lar reduction in recovery of Pol2p using the His6-Dpb2 was
observed with a second mutant protein, pol2-Ep, carrying a
deletion of aa 2143–2152 that fails to support growth at any
temperature (data not shown) (21).
Interactions between Pol2p and the Non-essential Subunits
Dpb3p and Dpb4p—To determine if the catalytic subunit also
interacted with Dpb3p and/or Dpb4p, Pol2p was expressed in
the presence of either His6-Dpb3p or His6-Dpb4p and Ni
21/
NTA chromatography was performed. Western blotting failed
to detect Pol2p copurifying with either His6-Dpb3p or His6-
Dpb4p alone (data not shown). However, the affinity-purified
Pol2p and His6-Dpb3p or Pol2p and His6-Dpb4p complexes did
contain DNA polymerase activity (Table I). This activity was 50
times higher than the background levels in His6-Dpb3p or
His6-Dpb4p affinity-purified from cells that did not express
recombinant yeast Pol2p (Table I). Thus, there may also be
direct interactions between Pol2p and Dpb3p and Dpb4p (Table
I). These interactions with Pol2p are weaker than Pol2p/Dpb2p
interaction, both as measured by Western blotting and DNA
polymerase activity recovered (Table I) (see also two-hybrid
analysis, Fig. 7).
Direct Interactions between Dpb2p, Dpb3p, and Dpb4p in the
Absence of Pol2p—Sf9 insect cells were coinfected with pairwise
combinations of His6-Dpb2pzDpb3p, His6-Dpb2pzDpb4p, His6-
Dpb3pzDpb4p, and Dpb3pzHis6-Dpb4p baculoviruses. Ni
21/NTA
affinity-purified proteins were monitored by Western blotting
using pol e antibody. The mobilities of the respective tagged
species are shown in Fig. 3 (lanes 5–7). Both untagged Dpb3p and
Dpb4p, which migrate slightly faster than the tagged proteins in
FIG. 1. Pol2p/Dpb2p interactions in pol complex. A, Western
blots of affinity-purified proteins. Sf9 insect cells (40 3 106 ) were
coinfected with Pol2p and His6-Dpb2p baculoviruses and expression
and purification of proteins was carried out as described under “Exper-
imental Procedures.” Proteins were analyzed by Western blotting using
pol e antibody. Lane 1T, total cell protein for cells infected with Pol2p
and His6-Dpb2p virus; lane 1E, protein from cells infected with Pol2p
and His6-Dpb2p bound to Ni
21/NTA and eluted with imidazole; lane 2T,
total cell protein for cells infected with Pol2p virus; lane 2E, protein
from cells infected with Pol2p virus only that bound to Ni21/NTA and
eluted with imidazole. B and C, interaction of 110-kDa Pol2p fragment
with Dpb2p. B, Western blot of HA-Pol2p (aa 1265–end) eluted from
Ni21/NTA after coinfection with His6-Dpb2p. HA-Pol2p (aa 1265–
end)zHis6-Dpb2p coinfection and the His6-Dpb2p infection were ana-
lyzed by Western blotting using pol e antibody. Lane 1, eluted protein
from HA-Pol2p (aa 1265–end)zHis6-Dpb2p coinfection; lane 2, control
showing eluted protein from His6-Dpb2p infection. C, protein fractions
of cells infected with HA-Pol2p (aa 1265–end) and His6-Dpb2p were
separated on 10% SDS-PAGE and bands were visualized by staining
with Coomassie Brilliant Blue. Lane 1, total cell protein (150 mg); lane
2, protein not bound to the Ni21/NTA column; lane 3, protein bound to
Ni21/NTA and eluted in the presence of 0.3 M imidazole (8 mg).
FIG. 2. Interaction of pol2-Fp with Dpb2p. A, suppression of
pol2-F by DPB2. The pol2-F yeast strain, harboring YEp18-DPB2 or
YEp18 only, was streaked on minus-tryptophan, minus-uracil minimal
medium plate containing raffinose and 2% galactose and incubated at
37 °C for 3 days. B, interaction between pol2-Fp and Dpb2p; Sf9 insect
cells (40 3 106) were coinfected with pol2-FpzHis6-Dpb2p, and proteins
were purified by Ni21/NTA affinity chromatography as described under
“Experimental Procedures.” The various protein fractions as shown in
the top of the figure were separated on 10% SDS-PAGE and analyzed by
Western blotting using pol e antibody. As indicated, lane 1 is from the
coinfection and lane 2 is a control in which pol2-Fp was not expressed.
Lane 1T, total protein loaded on Ni21/NTA column; lane 1E, protein
bound to and eluted from Ni21/NTA column; lane 2T, total protein; lane
2E, bound and eluted protein.
Protein/Protein Interactions in pol 28819
lanes 5 and 6, coeluted with His6-Dpb2p (Fig. 3, lanes 1 and 2).
Neither untagged Dpb4p nor untagged Dpb3p bound to the col-
umn in the absence of a His6 tag (data not shown). Thus, Dpb2p
interacts independently with Dpb3p or Dpb4p and interaction
doesn’t require Pol2p. Dpb3p coeluted with His6-Dpb4p and
Dpb4p coeluted with His6-Dpb3p in the coinfections (Fig. 3, lanes
3 and 4). This indicates that Dpb3p and Dpb4p form a direct
complex without Pol2p or Dpb2p to mediate their interaction.
The results in Figs. 1 and 3 suggest that Pol2p and Dpb2p form
a complex and that Dpb3p and Dpb4p form a complex. We pro-
pose that these two complexes may interact to form the holoen-
zyme as purified from yeast (4), although further studies will be
necessary to verify this hypothesis. This organization is consist-
ent with the recent results obtained with in vitro translation with
human pol e subunits (27).
The C Terminus of POL2 (aa 1265–end) Does Not Form a
Homodimer—Using yeast two-hybrid analysis, we have previ-
ously shown that the C terminus of POL2 (aa 1265–end),
lacking the entire polymerase domain, interacts with itself, i.e.
dimerizes. We also showed that the C terminus is sufficient for
interaction with DPB2 (Ref. 21, and see Fig. 1). To investigate
dimerization biochemically, we cloned the C-terminal half of
POL2 (aa 1265–end) in pfastHT1 and pfastHA baculovirus
vectors, which fuse POL2 (aa 1265–end) to the His6 peptide
and hemagglutinin (HA) epitope tags, respectively, and thus
produce 110-kDa polypeptides when expressed. Cells were
coinfected with His6-Pol2p (aa 1265–end) and hemagglutinin
epitope-tagged HA-Pol2p (aa 1265–end) recombinant baculovi-
ruses and Ni21/NTA-purified proteins were analyzed by West-
ern blotting using 12CA5 (for HA epitope) and pol e polyclonal
antibodies. Although both HA-Pol2p (aa 1265–end) and His6-
Pol2p (aa 1265–end) (Fig. 4, B and C) were clearly expressed
and present in the total cell lysate (Fig. 4A, lane 3T), the
Ni21/NTA affinity-purified His6-Pol2p fraction did not contain
detectable HA-Pol2p (aa 1265–end) (Fig. 4A, lane 3E). Recov-
ery of His6-Pol2p (aa 1265–end) from the Ni
21/NTA column
was verified by SDS-PAGE and Western blotting using pol e
antibody (Fig. 4, B and C). Control cells singly infected with
HA-Pol2p (aa 1265–end) or His6-Pol2p (aa 1265–end) or His6-
Dpb2 showed efficient expression of HA-Pol2p but no HA-Pol2p
in affinity column eluates (Fig. 4A, lanes 1, 2, and 4), as ex-
pected. The positive control in Fig. 4A (lane 5) shows that
HA-Pol2p is capable of binding and copurifying with His6-
Dpb2p and can be detected in a Ni21/NTA eluate. The experi-
ment was repeated using various salt concentrations (50–300
mM) during lysate preparation and affinity purification, but the
HA-Pol2p (aa 1265–end) was not detected in the eluted protein
fraction. Thus, the dimerization of Pol2p detected by the two-
hybrid system either is mediated by another protein not pres-
ent in insect cells or is too weak to survive the isolation proce-
dure used here in the absence of the N-terminal domain.
Dpb2p Forms a Homodimer—Since Pol2p does not itself ap-
pear to dimerize but does interact with Dpb2p, it seemed plau-
sible that dimerization might occur through Dpb2p. Although we
previously failed to find self interaction for DPB2 in the two-
hybrid system (21), we show below with a more sensitive two-
hybrid analysis that Dpb2 dimerization does occur. To test for
dimerization biochemically, His6-Dpb2p was purified from the
Sf9 insect cells and analyzed by gel filtration. To exclude the
possible interference by the N-terminal His6 epitope, we cleaved
the epitope by site-specific rTEV protease and the intact Dpb2p
was further purified. The protein was then injected onto a Su-
perdex 200 PC gel filtration column. The majority of the protein
was eluted at the apparent molecular mass of 160 kDa, as ex-
pected of a Dpb2p dimer (Fig. 5A). This confirms the two-hybrid
results presented below, and we propose that dimerization of
Pol2p may therefore occur through Dpb2p.
Further evidence for dimerization of Dpb2p was obtained
when we applied a His6-Dpb2pzHis6-Dpb3pzDpb4p affinity-puri-
fied mixture, prepared from coinfections of cells with the three
corresponding viruses, to the gel filtration column. SDS-PAGE
and silver staining of the protein fractions showed that a His6-
Dpb2pzHis6-Dpb3pzDpb4p complex eluted at 190 kDa (Fig. 5B).
The elution position suggests a 2Dpb2pz1Dpb3pz1Dpb4p complex,
assuming a globular complex.
Gel Filtration Analysis of Pol2pzDpb2p Complexes Reveals a
600-kDa Heterotetrameric Form—To assess whether Dpb2
dimerization might mediate Pol2p dimerization, we performed
gel filtration analysis of complexes isolated from cells coin-
TABLE I
Enzymatic activity of purified wild type and mutant pol e complexes
or subcomplexes by Ni21/NTA affinity chromatography
The polymerase activity of the complexes was measured using
poly(dA)/oligo(dT)10 (1:20) as DNA template. The assay conditions are
described under “Experimental Procedures.” The purifications were
done in parallel as were the assays, and 1–2 mg of protein was used in
the polymerase determination. Determinations were made a minimum
of three times, and the average is reported.
Enzyme Polymerase activity
units/mg of total protein
Pol2p only 2.3
His6-Dpb2 z 6xHis-Dpb3 z Dpb4 2.2
His6-Pol2p 1289
a
Pol2p z His6-Dpb2p 764
Pol2p z His6-Dpb3p 97
Pol2p z His6-Dpb4p 110
Pol2p z His6-Dpb2p z His6-Dpb3p z Dpb4p 1338
Pol2-Fp z His6-Dpb2p 126
Pol2-Fp z His6-Dpb2p z His6-Dpb3p z Dpb4p 548
a Please note that the specific activity is calculated based on the total
protein in the preparation. Thus, the apparently small difference in
specific activity between Pol2p and the four subunit complex is an
underestimate of the difference between them. Based on the concentra-
tion of the Pol2p peptide alone, we estimate that the specific activity is
at least 5-fold higher in the four-subunit complex. The His6-Pol2p is
estimated to be only 10% pure, is unstable, and has a molecular mass by
Western blotting of only 165 kDa, making comparison of the single-
subunit enzyme with the other preparations difficult. However, it is
presented for completeness. The lower extent of purification efficiency
for His6-Pol2p may be due to lower effective expression and instability
of the intact protein.
FIG. 3. Dpb2p, Dpb3p, and Dpb4p interactions. 40 3 106 Sf9
insect cells were infected with various pairwise combinations of His6-
Dpb2p, His6-Dpb3p, Dpb3p, His6-Dpb4p, and Dpb4p baculoviruses, and
proteins were purified by Ni21/NTA affinity chromatography as de-
scribed under “Experimental Procedures.” The bound proteins from
each infection as indicated were separated on 10% SDS-PAGE and
analyzed by Western blot analysis using pol e polyclonal antibody.
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fected with Pol2 and His6-Dpb2. A substantial amount of DNA
polymerase activity eluted in fractions 8–10, corresponding to
600 kDa. Both Pol2p and Dpb2p were present in these fractions
(Fig. 6A). Given that Pol2 is a 256-kDa protein and Dpb2 is an
80-kDa protein, the most likely composition of the protein in
this 600-kDa peak is a heterotetramer consisting of two
Pol2pzDpb2p heterodimers. Additional polymerase activity also
eluted at 210 kDa. Since this is smaller than Pol2p (256 kDa)
itself, this may represent proteolyzed fragments and we have
not analyzed this (these) species in detail. It is worth pointing
out that pol e activity has previously been isolated from yeast
and shown to contain a 120-kDa form of the Pol2p, and there is
a 120-kDa band in this fraction. Unlike here, that form was not
shown to be complexed with Dpb2p, Dpb3p, or Dpb4p (4, 5).
This polymerase activity was due to some form of Pol2p, how-
ever, since no polymerase was observed if His6-Dpb2p alone or
His6-Dpb2pzHis6-Dpb3pzDpb4p was applied to the column (Fig.
5). In fact, controls showed that no polymerase activity was
observed in any of the gel filtration experiments shown in this
work when Pol2p was omitted.
It was possible, since these experiments were carried out in
the absence of Dpb3pzDpb4p complexes, that the putative 600-
kDa complex might be an artifact and might not form in their
presence. To test this possibility, Sf9 insect cells were coin-
fected with Pol2p, His6-Dpb2p, His6-Dpb3p, and Dpb4p recom-
binant baculoviruses. All four proteins were recovered from the
affinity column, as revealed by Western blots (data not shown).
Gel filtration revealed a DNA polymerase peak at 600 kDa,
with the same mobility and composition (Fig. 6B) as the com-
plex formed in the absence of Dpb3p and Dpb4p (Fig. 6A).
Although there was no detectable Dpb3 or Dpb4 in the 600-kDa
FIG. 4. Failure of the 110-kDa C terminus of POL2 (aa 1265–
end) to dimerize. A–C, biochemical test for dimerization of the 110
kDa fragment. A, Western blot using anti-HA 12CA5 monoclonal anti-
body. Sf9 insect cells (40 3 106) were singly infected or coinfected in
pairwise combination with baculoviruses for His6-Pol2p (aa 1265–end),
HA-Pol2p (aa 1265–end), and His6-Dpb2p as indicated. After cell lysis,
the proteins were purified using Ni21/NTA affinity chromatography as
described under “Experimental Procedures.” Protein from the total cell
lysate (T) and bound protein fractions eluted with imidazole (E), were
separated on 10% SDS-PAGE and subjected to Western blotting using
12CA5 anti-HA epitope monoclonal antibody. B, protein from the cells
infected with His6-Pol2p (aa 1265–end) were separated on 10% SDS-
PAGE and the gel was stained with Coomassie Brilliant Blue. Lane 1,
total cell protein (150 mg); lane 2, protein that failed to bind to the
Ni21/NTA beads; lane 3, bound proteins (4 mg) eluted in the presence of
0.3 M imidazole. C, Western blot of extract and Ni21/NTA-bound frac-
tions using pol e antibody. Lane 1, unbound protein; lane 2, bound
protein eluted in the presence of 0.3 M imidazole.
FIG. 5. Dpb2p forms a homodimeric complex. A, gel filtration
analysis of affinity-purified His6-Dpb2p. The N-terminal His6 sequence
in His6-Dpb2p was cleaved by rTEV protease as described under “Ex-
perimental Procedures.” 10 mg of the purified Dpb2 was injected on the
Superdex 200 PC column, and protein fractions were separated by 10%
SDS-PAGE and silver staining. B, gel filtration analysis of affinity-
purified protein from a His6-Dpb2pzHis6-Dpb3pzDpb4p coinfection. 50
mg of the protein eluted from Ni21/NTA resin was injected on Superdex
200 PC column. The protein fractions were separated on 10% SDS-
PAGE and silver-stained. The polymerase activity was determined
using poly(dA)/oligo(dT) as described under “Experimental Procedures.”
Size markers were thyroglobulin (669 kDa), catalase (232 kDa), aldol-
ase (158 kDa), and bovine serum albumin (67 kDa).
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FIG. 6. Gel filtration analysis of Pol2pzDpb2 complexes reveals a heterotetrameric form. 80 mg of Pol2pzHis6-Dpb2p of the protein eluted
from the Ni21/NTA was injected onto a Superdex 200 PC column, and proteins were separated on 10% SDS-PAGE and silver-stained. The
polymerase activity of the protein fractions was determined using poly(dA)/oligo(dT) as described under “Experimental Procedures.” The size
markers were thyroglobulin (669 kDa), catalase (232 kDa), aldolase (158 kDa), and bovine serum albumin (67 kDa). B, gel filtration analysis of the
Pol2pzHis6-Dpb2pzHis6-Dpb3pzDpb4p affinity-purified sample. 50 mg of the protein eluted from the Ni
21/NTA was injected on Superdex 200 PC
column, and proteins were separated on 10% SDS-PAGE and silver-stained. The polymerase activity of the protein fractions was determined using
poly(dA)/oligo(dT) as described under “Experimental Procedures.” C, stabilization of pol2-FpzDpb2p complex by Dpb3p and Dpb4p. Sf9 cells (70 3
106 ) were coinfected with pol2-FpzHis6-Dpb2pzHis6-Dpb3pzDpb4p, and proteins were purified by Ni
21/NTA affinity chromatography. The various
protein fractions were subjected to 10% SDS-PAGE, and the resulting gel was stained with Coomassie Blue. Lane 1, total cell protein before
addition of Ni21/NTA-agarose (200 mg); lane 2, protein not bound to the beads; lane 3, proteins eluted in the presence of 0.3 M imidazole (20 mg).
D, Western blotting of pol2-FpzHis6-Dpb2pzHis6-Dpb3pzDpb4p. Protein fractions as described in Fig. 6C were analyzed by Western blotting using
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peak, there was more of the 600-kDa form compared with the
210-kDa (presumably) degraded form seen also in Fig. 6A.
Although it is not clear how Dpb3p and Dpb4p increase the
amount of the heterotetrameric peak, these data show at the
least that the heterotetramer form can be a major reproducible
form of this Pol2pzDpb2p subassembly. We speculate that the
apparent relative stabilization of the 600-kDa form by Dpb3
and Dpb4p may be related to the fact that coexpression of the
latter two subunits with Pol2pzDpb2p also results in an in-
crease in recovery of overall DNA polymerase activity (Table I).
It is noteworthy that, if Dpb3 and Dpb4 are not tagged with
His6, they do not copurify from extracts with His6-Pol2p nor
with Pol2pzHis6-Dpb2p (data not shown).
We next asked if the pol2-Fp mutant could form heterotetram-
ers with Dpb2p, even though its interaction with Dpb2p was
weak compared with wild-type Pol2p (see Fig. 2A). Sf9 cells were
coinfected with pol2-Fp, His6-Dpb2p, His6-Dpb3p, and Dpb4p
recombinant baculoviruses, and protein complex was purified
using Ni21/NTA chromatography. Coexpression of the His6-
Dpb3p and Dpb4p proteins appeared to stabilize the pol2-
FpzDpb2p complex since pol2-Fp now clearly coeluted with His6-
Dpb2p (compare Fig. 2B (lane 1E) with Fig. 6C (lane 3)). This
effect of Dpb3p and Dpb4p was reflected in increased recovery of
DNA polymerase activity (Table I). The increased recovery al-
lowed us to analyze the pol2-FpzHis6-Dpb2p complex by gel fil-
tration. In contrast to the results with wild type Pol2pzHis6-
Dpb2p (Fig. 6A), the polymerase activity of pol2-Fp mutant
eluted in a single peak at an apparent molecular mass of 190 kDa
(Fig. 6E), suggesting severe degradation. The striking reduction
of the amount of the 600-kDa Pol2pzDpb2p complex containing
pol2-Fp demonstrates that the inter-zinc finger mutation desta-
bilizes the Pol2pzDpb2p complex and reduces formation of the
heterotetramer. (We note parenthetically that a small amount of
polymerase may be found in fraction 6. Multimeric His6-Dpb2p is
also observed in fractions 5 and 6 (Fig. 6E). A small amount of
pol2-Fp is presumably present but below the level of detection by
silver staining in these fractions.)
The experiments in Figs. 5 and 6 have been repeated at least
twice, using at least two different infections; therefore, we
believe the amounts of activity and protein are reproducible.
We conclude that the inter-zinc finger domain stabilizes inter-
action between Pol2p and Dpb2p and therefore may be involved
in dimerization.
Semi-quantitative Analysis of Subunit Interactions Using the
Yeast Two-hybrid Assay—Although the fusion of proteins to
Gal4 required for implementation of the two-hybrid assay can
interfere with normal protein/protein interactions, neverthe-
less the approach has been successful in many cases in esti-
mating affinities between different proteins. To compare the
strength of the various protein/protein interactions described
above, we used a two-hybrid assay in which the reporter strain
has eight lexA operators in tandem controlling the lacZ gene
and four lexA operators controlling the HIS3 gene. Strong
protein/protein interactions show high levels of b-galactosidase
expression, but even weak interactions are detectable. The
POL2, DPB2, DPB3, and DPB4 genes were fused both to the
lexA DNA binding domain and to the Gal4 activation domain as
described under “Experimental Procedures.” The C-terminal
and N-terminal portions of POL2 were tested individually. The
strength of the interactions between the various proteins was
quantitated by measuring b-galactosidase activity in all possi-
ble pairwise combinations of the proteins. The results are col-
lated in Fig. 7. Supporting the biochemical evidence, the C
terminus of Pol2p interacted with Dpb2p, Dpb3p, and Dpb4p
(Figs. 1A and 3). The strength of the interactions was
Dpb2.Dpb3..Dpb4. Although we had previously failed to de-
tect DPB2 self-interaction in a two-hybrid assay with a less
sensitive reporter strain (21), with the current assay the inter-
action was easily detectable, as supported by the gel filtration
analysis that showed a homodimer (Fig. 5A). Although we have
shown that the C-terminal half of Pol2p is sufficient for inter-
action with Dpb2p, a fusion containing the N-terminal half of
Pol2p also showed weak interactions with Dpb2p, consistent
with the fact that high copy plasmids expressing high levels of
DPB2 suppress N-terminal temperature-sensitive pol2–18 mu-
tant (10). Dpb3pzDpb3p and Dpb4pzDpb4p homodimerization
was not observed under the same conditions, but there was a
very strong interaction between Dpb3p and Dpb4p, confirming
that they form a stable heterodimer (Fig. 3). Dpb2pzDpb3p and
Dpb2pzDpb4p showed very weak but detectable interaction,
again consistent with the recovery of co-complexes from the
Ni21/NTA column (Fig. 3).
An overview of these data is provided in the model shown in
Fig. 7. In summary, the C terminus of Pol2p interacts with
Dpb2p, Dpb3p, and Dpb4p. Dpb3p and Dpb4p directly interact
with each other in the absence of Pol2p and Dpb2p. Dpb2p
forms a homodimer and interacts with the N terminus of Pol2p
as well as the C terminus. The dimerization of the Pol2p C
terminus seen in the two-hybrid system is probably indirect
and may occur through interaction of two Pol2p subunits with
a Dpb2 dimer.
Point Mutations in the C-terminal Inter-zinc Finger Domain
of POL2—In our previous study, we showed that the pol2-E
and pol2-F mutants just described showed defects in DNA
replication and the S/M checkpoint (Fig. 8A and Ref. 21). Now
pol e antibody. E, gel filtration analysis of pol2-FzHis6-Dpb2pzHis6-Dpb3pzDpb4p. 50 mg of the eluted protein from Ni
21/NTA resin was injected on
Superdex 200 PC column. The protein fractions were separated on 10% SDS-PAGE and silver-stained. The polymerase activity was determined
using poly(dA)/oligo(dT) as described under “Experimental Procedures.”
FIG. 7. Yeast two-hybrid analysis. The L40 two-hybrid yeast
strain was used for the assay. C-term corresponds to amino acids
1265–2222, and N-term corresponds to amino acids 1–1265 of Pol2p.
The strain was transformed with the LexA DNA binding domain plas-
mid and Gal4 activation domain plasmid, and the colonies were selected
on Leu2/Trp2/His2 synthetic agar plates containing 1 mM 3-amino-
1,2,4-triazole. The colonies that grew were further analyzed by X-gal
filter lifts, and interactions were quantitated by b-galactosidase assays.
The measurements were done in replicates of 4–11 samples, and the
data are reported as an average. Numbers in parentheses are standard
deviation.
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we have provided further evidence that the defect lies in inter-
action with other subunits. However, it is not clear whether the
specific amino acid residues between the zinc fingers play an
essential role or if the deletions cause a structural change
adjacent to the amino acid residues. To investigate specific
amino acids, we made point mutations in two conserved
leucines (L2146D and L2150D) in the inter-zinc finger domain
(Fig. 8, A and B). The mutant proteins were analyzed for
complementation of a pol2D strain using a plasmid shuffling
assay as described previously (21). The pol2–310 and pol2–311
mutants, with L2146D or L2150D mutations, respectively,
showed no detectable growth defect. However, the pol2–312
mutant, with an L2146,L2150D double mutation, was inviable
at any temperature (Fig. 8C). These results strengthen the
conclusion that specific amino acids covered by the pol2-E
mutation are essential for cell viability, although it does not
prove that there is no structural change.
DISCUSSION
DNA polymerases are large molecular machines that play an
integral role in chromosomal replication. Polymerase e plays a
major role in the elongation stage of the replication of chromo-
somal DNA. Recently, a number of studies have indicated an
additional role of pol e in S/M checkpoint regulation, recombi-
nation, and transcriptional silencing (16, 19, 21, 28–31). By
site-specific deletion analysis in the putative zinc finger do-
main of POL2, we showed that the amino acid residues in the
inter-zinc finger domain are essential for DNA replication,
DNA repair, and the S/M checkpoint. We have also shown that
the putative zinc finger participates in protein/protein interac-
tions. In this study we have extended our analysis of the
inter-zinc finger domain of POL2 and its protein/protein inter-
actions. By point mutations, we showed that the two conserved
leucines in the inter-zinc finger domain are essential for the
cell viability. The essential nature of the leucine amino acid
residues suggests that protein/protein interactions mediated
through the inter-zinc finger could be mainly hydrophobic in
nature, although we cannot completely rule out ionic and hy-
drogen bond interactions, given the sequence shown in Fig. 8B.
A recent crystal structure analysis of a cocrystal containing the
phage RB69, “PCNA”-like sliding clamp and the C-terminal,
11-residue peptide of RB69 DNA polymerase showed that the
“PCNA” is bound in a hydrophobic pocket through Leu-897,
Met-900, and Phe-901 amino acid residues of the polymerase
peptide (32). The C-terminal 11 amino acid residues of the
polymerase have also been shown to be essential for the inter-
action of T4 DNA polymerase with the T4 sliding clamp (33). It
is possible that another subunit of pol e, Dpb2p, uses a similar
mode of interaction with Pol2p, as suggested by our compre-
hensive genetic and biochemical analysis of the pairwise pro-
tein/protein interactions between the various subunits of pol
ecomplex.
Studies of contacts between four of the subunits of pol e gave
the following picture of their organization. Pol2p forms a stable
complex with Dpb2p. The human homolog of Dpb2p also forms
a very tight complex with the mammalian Pol2p catalytic sub-
unit (12), suggesting a structural conservation between human
and yeast pol e complexes. Dpb3p and Dpb4p also form a strong
complex, and we propose that the Pol2pzDpb2p dimer interacts
with the Dpb3pzDpb4p dimer to form the holoenzyme isolated
from yeast by Sugino and colleagues (4). The proteins in the
Pol2pzDpb2p heterodimer can make multiple contacts with pro-
teins in the Dpb3pzDpb4p dimer. Pol2p interacts independently
with Dpb3p and Dpb4p, but the interactions are weaker than in
the presence of Dpb2p. The Pol2p/Dpb3p and Pol2p/Dpb4p
interactions are also much weaker than the Pol2p/Dpb2p in-
teraction (both biochemically and by two-hybrid analysis).
Dpb2p also interacts independently with Dpb3p and Dpb4p
(Fig. 3), but both purification of complexes from insect cells
infected with baculoviruses carrying all four subunits and two-
hybrid analysis suggests this interaction may be weak (Fig. 7).
The C terminus of Pol2p is sufficient to interact with Dpb2p. A
model for the interaction of the subunits is shown in Fig. 7.
Several studies based on purification of pol e activity from
yeast cells support the contacts suggested here. Pol e purified
from a dpb2-ts mutant lacked Dpb2p but contained Dpb3p (10).
This is consistent with our observation of a direct Pol2p/Dpb3p
FIG. 8. Characterization of the point
mutations affecting the putative inter-
zinc finger domain of POL2. A, sche-
matic diagram of putative zinc finger of
POL2. The pol2-E and pol2-F mutants
each containing site-specific 10 consecutive
amino acid deletion is highlighted in a box
(21). B, amino acid alignment showing the
conservation of leucine amino acid residues
in pol e from various sources. C, point mu-
tations in the conserved leucine. The mu-
tants were prepared as described under
“Experimental Procedures.” The mutant
pol2 genes were subcloned in the pRS314
vector and introduced into the A1128
pol2–3::LEU2(YEpPOL2) as described be-
fore (21). The transformants were replica
plated on agar plates lacking tryptophan
and containing 5-fluoroorotic acid (5-FOA)
at 24 °C and 370 °C for 4 days.
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contact. When pol e was purified from a dpb3D yeast strain,
Dpb2p copurified with Pol2p but Dpb4p was not present (11).
This can be explained if Dpb3p and Dpb4p interact more
strongly with each other than with Pol2p or Dpb2p and if
Dpb3p interacts more strongly with Pol2p than does Dpb4p
alone, as our results suggest (Fig. 7). By the same token, it is
possible that a dpb4D mutation would result in the dissociation
of Dpb3p from the pol e complex, although the interaction
between Dpb3p and Pol2p is stronger than between Dpb4p and
Pol2p by two-hybrid analysis (Fig. 7). Recent work on the
human pol e is also consistent with our findings.
We also attempted to produce the four-subunit pol e complex
by coexpressing baculoviruses containing all four subunit
genes (data not shown). We were not able to recover all four
proteins unless we tagged both Dpb2p and Dpb3p. Since our
experiment involved simultaneous coexpression of all four pro-
teins, it is possible that the four subunit complex must assem-
ble in a specific order. For instance, since we have established
that Dpb3p and Dpb4p interact with Pol2p, it is possible that
their interaction prevents proper association with Dpb2p. Such
precise order of assembly has been observed in the E. coli
replicase, where addition of g-d components before the addition
of t prevents t dimerization (34). Another possibility is that
another protein such as Dpb11p or Sld2p, which interact with
pol e, might be essential for proper assembly. Yet another
alternative is that Dpb3p and Dpb4p function by virtue of their
histone-fold motifs to allow entry of pol e into nucleosomes, as
recently proposed (27). Thus, Pol2pzDpb2p efficiently assemble
with Dpb3p and Dpb4p only in the context of chromatin. In
regard to a role for Dpb3p in chromatin structure, it is intrigu-
ing that dpb3 mutations were identified in a screen for genes
involved in rDNA silencing. The structure of silenced chroma-
tin in the rDNA locus may somehow be altered in dpb3 mutants
to allow transcription of the DNA (31). All four subunits of the
human enzyme have been shown to coimmunoprecipitate when
using an antibody to the Dpb4p homolog, p17, tagged with a
FLAG epitope (27).
Our biochemical analysis indicates that Pol2p dimerizes.
The dimerization of the Pol2p is most likely not direct (Fig. 4),
but instead occurs through homodimerization of the Dpb2p
subunit (Figs. 5–7). This situation is somewhat reminiscent of
the pol III9 form of the E. coli replicase described many years
ago by McHenry and O’Donnell laboratories (34), in which the
pol III core containing polymerase and proofreading nuclease
subunits is dimerized by interaction with a dimeric t subunit.
The pol e inter-zinc finger region is crucial for dimerization, as we
proposed previously (21), since gel filtration of the pol2-Fp mu-
tant complex did not show a heterotetrameric polymerase com-
plex, demonstrating that the mutation destabilizes Pol2p inter-
actions with Dpb2p. This was more directly verified by showing
that little pol2-Fp coeluted with His6-Dpb2p from the Ni
21/NTA
column. The overexpression of Dpb2p under the GAL1,10 pro-
moter suppressed the growth defect of the C-terminal pol2-F
temperature-sensitive mutant at the nonpermissive temperature
(Fig. 2), suggesting that we have identified a physiologically
significant interaction domain. It will be of interest to isolate and
examine the phenotype of dpb2 mutants that fail to dimerize.
The dimerization of pol e is interestingly different from the
dimerization of pol d. Pol31p, the B subunit of pol d which is
homologous to Dpb2p, does form a heterodimer with the cata-
lytic subunit, Pol3p. However, Pol31p does not form a ho-
modimer. Instead Pol31p interacts with PCNA and with the
third pol dsubunit, Pol32p. It is the latter subunit, Pol32p, that
homodimerizes and then leads to dimerization of the
Pol3pzPol31p heterodimer (35, 36). Recently, pol d from S.
pombe has also been shown to be a dimer of the heterotetramer
containing Pol3p, Cdc1p, Cdc27p, and Cdm1p and dimerization
was mediated by the essential Cdc27 subunit (37). Mutants of
pol d that fail to dimerize have not been described to date.
Although it is thought that leading and lagging strand elon-
gation are coordinated through the use of two different gene
products, pol d and pol e, one on each strand, obviating the need
for dimeric polymerases as are found in prokaryotes, a possible
role for dimeric polymerases in eukaryotes could be coordina-
tion of the two forks emanating from a single origin. The idea
that the two branch points of a bidirectional replication fork are
connected into a binary replisome was put forward as a mech-
anism for preventing rotation of the two forks with respect to
one another in order to reduce tangling of the sister chromatids
(38). Dimerization of the polymerases could both link the forks
physically and ensure synchronous activity at both forks. It has
previously been proposed that DNA helicases may also have an
organizational role in tethering forks to each other (39).
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